In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
The AMWAY ONE BY ONE® Campaign for Children is marking its 10th anniversary with a remarkable accomplishment – helping 10 million children live better lives.
Amway has been committed to providing people around the globe with hope and opportunity for more than five decades. In 2003, Amway chose to focus its charitable efforts on the single global social cause of helping children live better lives by harnessing the power of interpersonal and business relationships made possible by Amway distributors and employees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55864-amway-one-by-one-campaign-for-children-10th-anniversary
http://www.youtube.com/watch?v=y3WumX739XY
Paul Rudd ft Sam Calver - Wake The World Tonight OFFICIAL Video!
Paul is back with a summer smash after his No1 US Fusion Dance Chart hit with Amanda Wilson and Trust In Me.
The new single is released July 15th with mega remixes from Andi Durrant & Steve More, Cutmore, Mark Loverush & TImothy Allan and Mikael Wills!!!!
It already has support from the likes of Gareth Emery, Seb Fontaine, Marcus Schulz, Freemasons, Andi Durrant, Capital FM, Cutmore to name a few..
This is the Timothy Allan vs Mark Loverush remix on the video, get your copy and all the mixes here https://itunes.apple.com/gb/album/wake-world-tonight-feat.-sam/id672277820
For management, booking and info please contact Anthony Burr (More Than Me) Anthony@morethanme.co.uk @MoreThananthony 0207 099 0680
With the help of this video see how easily Exchange 2010 recovers lost folders and conversion program is executed with single Exchange recovery software.Know more:- http://www.edbtopsttrial.net/exchange-2010-recover-lost-folders.html
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
